Berkshire Asset Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-2,127
Closed -$645K 171
2015
Q2
$645K Buy
+2,127
New +$645K 0.11% 97
2015
Q1
Sell
-945
Closed -$201K 174
2014
Q4
$201K Buy
+945
New +$188K 0.03% 162
2014
Q3
Sell
-1,224
Closed -$207K 181
2014
Q2
$207K Buy
+1,224
New +$191K 0.04% 163

Other funds holding AGN

Berkshire Asset Management's AGN Position: Q3 2015 in Review

Berkshire Asset Management sold out of Allergan Inc (AGN) in Q3 2015, closing a stake of 2,127 shares — an estimated $645K sold.

Berkshire Asset Management first reported a position in AGN in Q2 2014 and held it in 3 quarters. The position peaked at $645K in Q2 2015. 27 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Berkshire Asset Management reported no remaining Allergan Inc position as of Q3 2015 after selling out during the quarter.
  • Berkshire Asset Management sold 2,127 Allergan Inc shares in Q3 2015, an estimated $645K.
  • Berkshire Asset Management first reported a position in Allergan Inc in Q2 2014 and held it in 3 quarters.
  • Berkshire Asset Management's Allergan Inc position peaked at $645K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2015.

Based on Berkshire Asset Management's 13F filing for Q3 2015, filed 13 Oct 2015.